Troponin Elevation and Myocardial Injury in Patients Admitted to an Internal Medicine Department: Diagnostic and Prognostic Significance

Authors

DOI:

https://doi.org/10.24950/O/69/20/3/2020

Keywords:

Myocardial Infarction / diagnosis, Troponin, Troponin I

Abstract

Introduction: An elevated troponin is often found in patients admitted to the hospital. The meaning and the classifications of patients with this elevation (myocardial injury, either acute or chronic, versus acute myocardial infarction, either type 1 or type 2) remains unclear. The aim of our study was to assess the meaning and to classify the patients admitted to an internal medicine department with an elevated troponin level.

Material and Methods: A clinical retrospective analysis of hospitalized patients admitted to an internal medicine department was conducted over a 2-year period. We identified patients with at least 2 troponin I measurements, and at least 1 above 0.1 ng/mL. Population was characterized according to demographics, cardiovascular risk factors, clinical presentation, treatment and prognosis. Troponin elevation was interpreted according to the fourth univer-sal definition of myocardial infarction.

Results: A total of 90 patients were enrolled, with a mean age of 83 years ((± 8.1), 52% were male. Sixty patients (66%) had myocardial infarction criteria, and the remaining 30 patients (33%) were classified as acute myocardial injury, without infarction. We found no clinical difference between these patients, except for age, which was higher in myocardial infarction patients (84 ± 7 vs 81 ± 10 years, p = 0.039). Patients had a high disability score (43% had an ECOG 3 or 4), hypertension (89%), heart failure (51%), type 2 diabetes (50%), chronic kidney failure (35%), atrial fibrilation or flutter (35%) and had had a previous myocardial infarction (33%). Clinical presentation included dyspnea (44%) and chest pain (13%). On discharge, pa-tients were prescribed a statin (64%) and antiplatelets (58%). In-hospital mortality was 17%, while 30 days and 1 year mortality were 27% and 51% respectively.

Conclusion: In this study, in a real-world cohort of patients admitted to an Internal Medicine department over a 2-year period, troponin levels were analyzed in 9%, and acute myocardial injury was found in one third of those patients. These patients had criteria for acute myocar-dial infarction in 66% and of acute myocardial injury without infarction in 33%. Age was higher in myocardial infarction patients, whilst there were no differences in other clinical, management or prognostic features. Patients were elderly and fragile, with a higher prevalence of several comorbidities, when compared with studies based on Cardiology departments. Mortality was high, with half the patients dying within a year, even with the prescription of statins in 64% and antiplatelets in 60%.

Downloads

Download data is not yet available.

References

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal defi-nition of myocardial infarction. J Am Coll Cardiol. 2018;72:2231-64. doi: 10.1016/j.jacc.2018.08.1038.

Saaby L, Poulsen TS, Diederichsen ACP, Hosbond S, Larsen TB, Schmidt H, et al. Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort. Am J Med. 2014;127:295-302.

López-Cuenca A, Gómez-Molina M, Flores-Blanco P, Sánchez-Martínez M, García-Narbon A, Heras-Gómez I, et al. Comparison between type-2 and type-1 myocardial infarction: clini-cal features, treatment strategies and outcomes. J Geriatr Cardiol. 2016;13:15-22. doi: 10.11909/j.issn.1671-5411.2016.01.014.

Baron T, Hambraeus K, Sundström K, Erlinge D, Jernberg T, Lindahl B. Type 2 myocardial infarction in clinical practice. Heart. 2015;101:101-6. doi: 10.1136/heartjnl-2014-306093.

Smilowitz NR, Weiss MC, Mauricio R, Mahajan AM, Dugan KE, Devanabanda A, et al. Pro-voking conditions and outcomes of type 2 myocardial infarction and myocardial necrosis. Int J Cardiol. 2016;218:196-201. doi: 10.1016/j.ijcard.2016.05.045.

Morrow DA, Cannon C, Jesse R, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. J Clin Chem. 2007;53:552-74.

Oken M, Creech R, Tormey D, Horton J, Davis TE, McFadden ET, et al. Toxicity And Re-sponse Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55.

Shah A, McAllister DA, Mills R, Lee KK, Churchhouse A, Fleming KM, et al. Sensitive Tro-ponin Assay and the Classification of Myocardial Infarction. Am J Med. 2015;128:494-501. doi: 10.1016/j.amjmed.2014.10.056.

Stein G, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, et al. Type-II Myocardial Infarction – Patient Characteristics, Management and Outcomes. PLoS One. 2014;9:e84285. doi: 10.1371/journal.pone.0084285.

Szymanski F, Karpinski G, Platek A, Majstrak F, Hrynkiewicz-Szymanska A, Kotkowski M, et al. Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction. Kardiol Pol. 2014;72:339-44. doi: 10.5603/KP.a2013.0284.

Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Wildi K, Breitenbücher D, et al. Effect os definition on incidence and prognosis of type 2 myocardial infarction. J Amn Coll Cardiol. 2017;70:1558-68. doi: 10.1016/j.jacc.2017.07.774.

Javed U, Aftab W, Ambrose J, Wessel RJ, Mouanoutoua M, Huang G, et al. Frequency of Elevated Troponin I and Diagnosis of Acute Myocardial Infarction. Am JCardiol. 2009;104:9-13.

Saaby L, Poulsen TS, Hosbond S, Larsen TB, Diederichsen AC, Hallas J, et al. Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction. Am J Med. 2013;126:789-97.

Masson S, Anand I, Favero C, Barlera S,Vago T,Bertocchi F, et al. Serial measurements of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from two large randomized clinical trials. Circulation. 2012;125:280-8.

Pavasini R, dAscenzo F, Campo G,Biscaglia S,Ferri A,Contoli M, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol. 2015;191:187-93. doi: 10.1016/j.ijcard.2015.05.006.

Peacock W, Marco T, Fonarow G, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. NEJM. 2008;358:2117-26.

Gupta S, Vaidya S, Arora S, Bahekar A, Devarapally S. Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies. Cardiovasc Diagn Ther. 2017;7:348-58. doi: 10.21037/cdt.2017.03.21.

Downloads

Published

2021-09-30

How to Cite

1.
Carrington M, Jacinto M, Sousa A, Sant’Anna J, Muñoz J, Tribolet de Abreu T. Troponin Elevation and Myocardial Injury in Patients Admitted to an Internal Medicine Department: Diagnostic and Prognostic Significance. RPMI [Internet]. 2021 Sep. 30 [cited 2024 May 20];27(3):229-35. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/119

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 > >>